What Parallel Health does

Parallel Health, Inc. is a precision skin health company founded in 2021 and headquartered in San Francisco that has built an integrated platform combining whole genome skin microbiome sequencing, AI-driven analytics, personalized bacteriophage therapy, and tele-dermatology under the Microbiome Dermatology brand. Its flagship offering, the MD-03 Protocol, is a recurring subscription product that pairs an at-home Skin Discovery Test using quantitative WGS with a 1:1 clinical consultation and a custom Active Phage Serum formulated to the consumer's Skin Microbiome Type, priced at approximately $195 per month with a three-month minimum. The company also sells complementary skincare (Blue Biotic peptide cream, Holy Calming Cleanser, Skin Barrier Biotic Cream), a la carte microbiome tests ($495), custom compounded prescriptions, and condition-specific protocol extensions covering acne, eczema, rosacea, hidradenitis suppurativa, scalp, and body odor. Backed by a proprietary biorepository of more than 10,000 characterized microbial strains and eight pending patents, Parallel positions its approach as functional, root-cause dermatology rather than symptomatic treatment.

The company monetizes through four primary streams: MD-03 subscription recurring revenue, individual skincare product sales, one-time test kit purchases, and a clinical research services offering that licenses quantitative microbiome analysis, strain discovery, and formulation support to CPG and therapeutic companies. Distribution is multi-channel: a Shopify-powered DTC e-commerce site with global shipping, US telehealth prescription fulfillment in four states (CA, NY, FL, TX), employer corporate wellness partnerships, and clinical research sales. As of 2026 Parallel has secured in-network status with three major US insurance carriers (Aetna, Cigna, UnitedHealthcare) in California, making it the only microbiome dermatology platform with multi-carrier insurance coverage in the country. The company operates with a lean team of 1-10 employees, has raised approximately $1.95 million in disclosed funding across 2021-2022, and is led by co-founders Natalise Kalea Robinson (CEO, Stanford GSB MBA) and Dr. Nathan Brown (CSO), with Dr. Seaver Soon serving as Medical Director.

Name

Parallel Health

Legal name

Parallel Health, Inc.

Website

https://www.parallelhealth.io/

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Parallel Health is a San Francisco precision skin health company that combines quantitative whole-genome skin microbiome sequencing, AI analytics, personalized bacteriophage therapy, and tele-dermatology to deliver its MD-03 Protocol and condition-specific skincare to individual consumers, with growing clinical research services for CPG and therapeutic clients.

Ownership category

akta.pro rank

Product category

Microbiome Dermatology / Precision Skincare

NAICS

Cosmetics, Beauty Supplies, and Perfume Retailers (456120), Medical and Diagnostic Laboratories (6215)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Services-Medical Laboratories (8071), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

Keywords

• Microbiome dermatology
• Skin microbiome testing
• Phage therapy skincare
• Precision dermatology
• Telehealth dermatology

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

1. MD-03 Protocol Subscription: Recurring monthly subscription model for the MD-03 Protocol combining Skin Discovery Test, 1:1 clinical consultation, and Custom Active Phage Serum at $195/month. Initial Skin Discovery Test is free after month 1 (valued at $495). Requires minimum three-month commitment for subscription products.
2. Skincare Product Sales: Direct-to-consumer e-commerce sales of skincare products including Blue Biotic Multi-Effect Peptide Cream ($295), Holy Calming Cleanser ($55), Skin Barrier Biotic Cream ($135), and Custom Compounded Prescriptions ($95). Products sold individually or through subscription.
3. Clinical Research Services: Partnership services for CPG and therapeutic companies including custom discovery programs, strain licensing, formulation support, clinical validation, and regulatory support for microbiome analysis.
4. Microbiome Test Kits: A la carte sales of skin microbiome test kits including Facial Skin Discovery Test ($495), Body Spot Test, Scalp Health Test, and Odor Discovery Test for individual purchase outside of subscription.

Pricing tiers

Go-to-market motion4 records

Distribution channels6 records

Marketing channels7 records

Core offering

Parallel Health sells the MD-03 Protocol™, a precision skin health system that combines at-home quantitative whole genome sequencing skin microbiome testing, 1:1 telehealth consultations with board-certified dermatologists, and custom-compiled active phage serums personalized to each customer's Skin Microbiome Type™. The company also sells individual precision skincare products (Blue Biotic™ Peptide Cream, Holy Calming Cleanser, Skin Barrier Biotic™ Cream), stand-alone microbiome test kits, custom compounded prescriptions, and condition-specific protocols for acne, eczema, rosacea, body odor, hidradenitis suppurativa, and scalp issues, available via subscription or à la carte purchase.

Product overview

Parallel Health is a vertically integrated precision skin health platform offering a portfolio of products centered on its Microbiome Dermatology™ approach. The core offering is the MD-03 Protocol™, a 3-step system combining at-home skin microbiome testing via whole genome sequencing, 1:1 telehealth consultations with dermatologists, and custom compounded phage serums. Supporting products include the Blue Biotic™ Multi-Effect Peptide Cream (anti-aging), Holy Calming Cleanser, Skin Barrier Biotic™ Cream, and various condition-specific protocols (Acne, Eczema, Rosacea, Hidradenitis Suppurativa, Scalp, Body Odor). The company also offers clinical research services using its proprietary quantitative whole genome sequencing platform. Products are available direct-to-consumer via subscription and a la carte, with insurance coverage in California through Aetna, Cigna, and UnitedHealthcare.

Differentiator

Problem solved

Functional benefit

Brands

• MD-03 Protocol: Flagship 3-step protocol combining whole genome sequencing, phage technology, and 1:1 provider care for personalized skin health treatment.
• Blue Biotic
• Skin Barrier Biotic
• Holy Calming Cleanser
• Daily Rewind Duo
• Daily Reset Duo

Products and services

• MD-03 Protocol™ Flagship 3-step precision skin health protocol combining at-home quantitative whole genome sequencing skin microbiome testing, 1:1 dermatologist telehealth consultation, and custom active phage serum delivery. Addresses aging, acne, eczema, rosacea, melasma, body odor, scalp, and hidradenitis suppurativa. Sold as a monthly subscription at $195/month with a 3-month minimum commitment.
• Blue Biotic™ Multi-Effect Peptide Cream Microbiome-based anti-aging peptide cream with 34 clinically proven ingredients. Claims 63% wrinkle reduction in 28 days and 100-150% increase in collagen production. Positioned as a non-invasive Botox alternative. Sold at $295 per unit.
• Daily Rewind Duo Anti-aging skincare duo product combining two formulations for comprehensive skin renewal.
• Daily Reset Duo Bundle containing Holy Calming Cleanser and Skin Barrier Silk Cream for daily cleansing and moisturizing.
• Custom Compounded Prescription Personalized prescription formulations prescribed by board-certified dermatologists based on individual medical needs and microbiome profile, targeting conditions like acne, rosacea, and melasma. Priced at $95 per prescription; limited to California, New York, Florida, and Texas.
• Skin Barrier Biotic™ Cream Moisturizer combining probiotics, prebiotics, and postbiotics with barrier-repairing ceramides and soothing allantoin for microbiome support. Priced at $135 per unit.
• Holy Calming Cleanser Microbiome-friendly cleanser containing proprietary prebiotic extracts to support calm skin and better aging, gently hydrating and nourishing sensitive skin. Priced at $55 per unit.
• Facial Skin Discovery Test At-home skin microbiome test using whole genome sequencing to provide comprehensive report of microbial composition, skin age, diversity, and health factors. Retail value $495.
• Body Spot Test Skin microbiome test for problem areas on the body to discover microbial composition and learn how to improve balance.
• Odor Discovery Test Skin microbiome test to discover odor profile and learn what makes up unique body scent.
• Scalp Health Test Comprehensive scalp microbiome analysis through simple swab, providing insights into individual scalp health and microbial profile with dermatologist consultation.
• Custom Active Phage Serum Personalized phage serum with nourishing ingredients and precision phage cocktail designed for individual skin microbiome, delivered as part of MD-03 Protocol.
• MD-03 Scalp Protocol™ Personalized teledermatology solution addressing scalp health concerns like hair loss and irritation using microbiome-focused approach. Condition-specific variant of the MD-03 Protocol.
• MD-03 Body Odor Protocol™ Personalized microbiome dermatology approach to manage body odor through tailored treatments including skin microbiome test and custom phage serum. Condition-specific variant of the MD-03 Protocol.
• MD-03 Hidradenitis Suppurativa Protocol™ Personalized treatment to identify bacterial causes and manage HS flare-ups through targeted therapies including microbiome test and customized prescriptions. Condition-specific variant of the MD-03 Protocol.
• MD-03 Eczema Protocol™ Personalized teledermatology approach to managing eczema featuring skin microbiome test, custom phage serum, and ongoing medical guidance. Condition-specific variant of the MD-03 Protocol.
• MD-03 Rosacea Protocol™ Personalized treatment plan targeting root causes of rosacea including redness and inflammation through customized phage therapy and prescriptions. Condition-specific variant of the MD-03 Protocol.
• Quantitative Whole Genome Sequencing Clinical Research Platform Proprietary clinical research technology providing absolute microbial quantification, comprehensive taxonomic coverage (bacteria, fungi, viruses, bacteriophages), and functional genomic insights including virulence factors and metabolic pathways. Offered as a B2B service for CPG and therapeutic companies, clinical researchers, and academic institutions.

Quantifiable outcome

• 99.9% reduction in inflammation and blemishes in dermatologist-led study
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration11 records

AI capability4 records

Feature7 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• UnitedHealthcarecoreChannel Partner/ Reseller/ Distributor · 7 April 2026Parallel Health achieved in-network status with UnitedHealthcare in California, expanding access to its Microbiome Dermatology platform. Allows Californians with UnitedHealthcare plans to access personalized skin health care through telehealth at in-network rates, covering over 49 million members nationally.
• Cigna HealthcarecoreChannel Partner/ Reseller/ Distributor · 19 February 2026Parallel Health achieved in-network status with Cigna Healthcare in California, marking its second major national insurance carrier partnership. Establishes Parallel Health as the only microbiome dermatology platform with multi-carrier insurance coverage in the United States.
• AetnacoreChannel Partner/ Reseller/ DistributorIn-network status with Aetna in California, following an earlier partnership. First major national insurance carrier partnership establishing Parallel Health as the only microbiome dermatology platform with multi-carrier insurance coverage in the US.
• Illumina AcceleratorminorStrategic or Co-development PartnerAccelerator program participant providing access to Illumina's genomics technology and resources for advancing microbiome sequencing capabilities.
• Stanford StartXminorStrategic or Co-development PartnerAccelerator program participant at Stanford University providing startup support, mentorship, and resources.
• TechCrunch Disrupt BattlefieldminorStrategic or Co-development PartnerCompeted as TOP 6 (TOP 0.2%) finalist at TechCrunch Disrupt startup competition, gaining visibility and recognition in the startup ecosystem.
• CPG and Therapeutic CompaniesminorStrategic or Co-development PartnerStrategic partnership opportunities for CPG and therapeutic companies including custom discovery programs, strain licensing, formulation support, clinical validation, and regulatory support using Parallel Health's quantitative microbiome analysis platform.

Scale indicators6 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Curology: Telehealth dermatology provider offering personalized prescription skincare for acne and anti-aging via subscription. Closest direct competitor in the personalized tele-derm + custom Rx category Parallel operates in.
• Apostrophe: Online dermatology practice delivering customized compounded prescription skincare. Directly comparable business model of telehealth consultation + custom compounded Rx delivered to consumer.
• Atolla: Data-driven personalized skincare using at-home testing to formulate serums. Highly comparable on the test-driven, custom-formulation, DTC-subscription model.
• Proven Skincare: AI-personalized skincare brand using a personalization quiz and custom-formulated products. Comparable on the AI-driven, custom formulation, DTC model aimed at anti-aging consumers.
• Mother Dirt: Microbiome-focused skincare brand built around live bacterial topical products. Direct peer in the consumer microbiome skincare category, sharing Parallel's positioning.
• Codex Beauty: Microbiome-focused clinical skincare brand with a BiaSkin platform combining prebiotics, probiotics and postbiotics. Comparable on microbiome + clinical claims positioning.

Broad incumbents

• Hims & Hers Health: Large public telehealth platform that has expanded into dermatology and personalized skincare. Competes in tele-derm and custom Rx but as part of a much broader men's/women's health portfolio.

Emerging players

• Sundial Skin: Early-stage microbiome skincare brand targeting acne and chronic skin conditions with proprietary topical strains. Emerging player in adjacent microbiome skincare niche.
• DermaDNA: Genetic and microbiome-based personalized skincare offering tailored regimens from DNA and skin analysis. Emerging player in the personalized skincare diagnostics category.
• SkinDNA: Genetic-based skincare analysis and product recommendation platform. Adjacent personalized skincare diagnostics peer leveraging biological data for custom regimen recommendations.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Instagraminstagram.com/yourtrueparallel
• Xx.com/urtrueparallel
• Facebookfacebook.com/yourtrueparallel

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds3 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Parallel Health